Rigel Pharmaceuticals RIGL Total costs & expenses
Total costs & expenses at other companies
Other financials
Where this comes from
Reported directly by Rigel Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:CostsAndExpenses.
The official record: Rigel Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Rigel Pharmaceuticals's total costs & expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Rigel Pharmaceuticals's total costs & expenses?
- Rigel Pharmaceuticals (RIGL) reported total costs & expenses of $46.93M in Q1 2026.
- How has Rigel Pharmaceuticals's total costs & expenses changed year-over-year?
- Rigel Pharmaceuticals's total costs & expenses increased by 15.7% year-over-year, from $40.56M to $46.93M.
- What is the long-term trend for Rigel Pharmaceuticals's total costs & expenses?
- Over 4 years (2021 to 2025), Rigel Pharmaceuticals's total costs & expenses has grown at a 1.1% compound annual growth rate (CAGR), from $161.73M to $168.82M.
- What does total costs & expenses mean?
- This metric represents the aggregate of all operating and non-operating costs incurred by the company to support its business activities, including research and development, selling, general, and administrative expenses, and cost of product sales. It serves as a comprehensive measure of the total resource consumption required to sustain operations and bring pharmaceutical products to market. Monitoring this figure allows investors to evaluate the company's overall cost structure and operational efficiency relative to its revenue generation.